FIRINU, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 208.528
NA - Nord America 6.324
AS - Asia 1.388
AF - Africa 32
SA - Sud America 30
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
Totale 216.322
Nazione #
IT - Italia 206.694
US - Stati Uniti d'America 6.261
CN - Cina 742
SE - Svezia 555
UA - Ucraina 415
SG - Singapore 297
DE - Germania 220
FI - Finlandia 183
GB - Regno Unito 171
VN - Vietnam 103
FR - Francia 81
CA - Canada 53
NL - Olanda 53
KR - Corea 48
TR - Turchia 39
HK - Hong Kong 34
IN - India 28
IR - Iran 24
BE - Belgio 23
IE - Irlanda 19
ES - Italia 17
RU - Federazione Russa 16
AU - Australia 14
ID - Indonesia 14
CO - Colombia 12
PT - Portogallo 10
IL - Israele 9
AT - Austria 8
BR - Brasile 8
CZ - Repubblica Ceca 8
JP - Giappone 8
TW - Taiwan 8
ZA - Sudafrica 8
MY - Malesia 7
LT - Lituania 6
PH - Filippine 6
CH - Svizzera 5
CL - Cile 5
DK - Danimarca 5
HU - Ungheria 5
MK - Macedonia 5
MX - Messico 5
NG - Nigeria 5
RO - Romania 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
EU - Europa 4
IQ - Iraq 4
HR - Croazia 3
KE - Kenya 3
NO - Norvegia 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
KW - Kuwait 2
LU - Lussemburgo 2
LY - Libia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PK - Pakistan 2
PL - Polonia 2
PR - Porto Rico 2
RS - Serbia 2
SD - Sudan 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
GE - Georgia 1
HN - Honduras 1
IS - Islanda 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
MT - Malta 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 216.322
Città #
Cagliari 200.668
Uta 5.077
Fairfield 799
Woodbridge 559
Chandler 534
Boardman 509
Ashburn 462
Houston 454
Nyköping 405
Wilmington 323
Seattle 275
Cambridge 251
Ann Arbor 246
Jacksonville 204
Singapore 177
Shanghai 151
Santa Clara 145
Helsinki 124
Dearborn 110
Beijing 103
Dong Ket 102
Boston 90
Nanjing 82
New York 80
Rome 77
San Diego 69
Redwood City 62
Milan 61
Los Angeles 46
Guangzhou 38
Toronto 35
Seoul 34
London 32
Nanchang 31
Hong Kong 28
Washington 28
Verona 27
Changsha 26
Jiaxing 25
Shenyang 24
Kocaeli 21
Monserrato 21
Mountain View 19
Sassari 19
Brussels 18
Norwalk 18
Redmond 17
Zhengzhou 16
Bari 15
Wuhan 15
Hebei 14
Munich 14
Paris 14
Tianjin 14
Turin 14
Amsterdam 13
Jinan 12
Vicenza 12
Florence 11
Orange 11
Sestu 11
Chicago 10
Jakarta 10
Phoenix 10
Rheinfelden 10
Shenzhen 10
Frankfurt am Main 9
Naples 9
Quartu Sant'Elena 9
Rotterdam 9
Auburn Hills 8
Dublin 8
Gyeongsan-si 8
Hangzhou 8
Leawood 8
Ningbo 8
Palermo 8
Romainville 8
San Mateo 8
Augusta 7
Bogazici 7
Borås 7
Brno 7
Vienna 7
Brooklyn 6
Chennai 6
Dallas 6
Pune 6
Quartu Sant'elena 6
Andover 5
Atlanta 5
Bogotá 5
Columbus 5
Cork 5
La Spezia 5
Ploaghe 5
Salerno 5
Seregno 5
Tortolì 5
Truccazzano 5
Totale 213.170
Nome #
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series 20.525
Overexpression of the cytokine BAFF and autoimmunity risk 3.907
TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome 3.891
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 3.755
The salivary proteome profile in patients affected by SAPHO syndrome characterized by a top-down RP-HPLC-ESI-MS platform 3.721
Systemic lupus erythematosus occurring in a patient with Niemann-Pick type B disease. 3.405
Gastrointestinal Coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management 3.118
Zinc status and autoimmunity: A systematic review and meta-analysis 2.933
The Salivary Proteome Profile in Patients Affected by SAPHO Syndrome characterized by a top-down RP-HPLC-ESI-MS platform 2.888
Characterization of patients with angioedema without wheals: The importance of F12 gene screening 2.640
Fungal allergy in asthma 2.619
Proteomic Analysis of the Acid-Insoluble Fraction of Whole Saliva from Patients Affected by Different Forms of Non-histaminergic Angioedema 2.616
Exercise-induced anaphylaxis with an Ayurvedic drug as cofactor: A case report 2.609
Alteration of the salivary secretory proteome profile in adults affected by antibody deficiency diseases 2.607
SAPHO Syndrome: Current developments and approaches to clinical treatment 2.582
Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis 2.537
COVID-19 in the mediterranean area: Epidemiology and main disease characteristics - A narrative review 2.533
RP-HPLC-ESI-IT Mass Spectrometry Reveals Significant Variations of the Human Salivary Protein Profile Associated with Predominantly Antibody Deficiencies 2.493
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 2.431
Biological treatments for SAPHO syndrome: an update 2.344
Impaired endothelial function in hereditary angioedema during the symptom-free period 2.292
Evaluation of olfactory function as a potential biomarker in patients with Mastocytosis 2.275
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 2.199
Oxidative stress markers in patients with hereditary angioedema 2.187
Baricitinib exposure during pregnancy in rheumatoid arthritis 2.172
Alteration of the Salivary Secretory Proteome Profile in Adults Affected by Immune Deficiency Diseases 2.156
Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie = Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic 2.111
Increased peripheral T(H)17 Cells in SAPHO syndrome: a novel target for treatment? 2.103
Biologics for ANCA-associated vasculitis 2.098
Genetic variants regulating immune cell levels in health and disease 2.024
Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study 2.022
An uncommon cause of refractory pleural effusion in an elderly patient 1.913
Clinical pitfalls of leishmaniasis and Whipple’s disease hidden behind systemic lupus erythematosus: A case series 1.891
Periodic fever syndromes and autoinflammatory diseases: a case series from an Italian centre 1.890
The role of genetics in the current diagnostic workup of idiopathic non-histaminergic angioedema 1.847
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 1.831
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 1.829
Vaping effects on asthma: results from a web survey and clinical investigation 1.813
Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather? 1.780
Mutation of angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema 1.731
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma 1.691
Asthma and psychiatric disorders 1.683
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 1.652
Relevance of essential trace elements in nutrition and drinking water for human health and autoimmune disease risk 1.638
Genetic factors associated with levels of immune cell types 1.614
The climate in the European Union and the enlarged European Region is a determinant of the COVID-19 case fatality ratio 1.571
Influenza burden, prevention and treatment in asthma - a scoping review by the EAACI Influenza in Asthma Task Force 1.528
The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study 1.512
Exercise and asthma: an overview 1.507
EAACI Biologicals Guidelines—Recommendations for severe asthma 1.503
Seroprevalence of SARS-Cov-2 in the setting of a non-dedicated COVID-19 hospital in a low CoV-2 incidence area: Implications for surgery 1.498
Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans with Posaconazole 1.497
Granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency: a case report 1.475
Is hereditary angioedema related to an increased risk of atherosclerosis? 1.441
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma 1.426
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype 1.416
Management of Intermittent and Persistent Asthma in Adolescent and High School Athletes 1.399
Hyperosinophilia and recurrent angioedema in a patient with giant cell arteritis: a diagnostic "glitch" in a case of Gleich's syndrome 1.388
The COVID-19 incidence in Italian regions correlates with low temperature, mobility and PM10 pollution but lethality only with low temperature 1.378
A Beacon in the Dark: Canakinumab. A New Therapeutic Perspective in Chronic Tophaceous Gout 1.359
Identification of a novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema 1.322
Celiac disease: peripheral blood cell-mediated response to antigen-specific stimulation 1.314
Biologics for SAPHO syndrome: a single centre experience 1.300
Exercise training, lymphocyte subsets and their cytokines production: experience of an Italian professional football team and their impact on allergy 1.281
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.268
Eosinophilic granulomatosis with polyangiitis relapse after covid-19 vaccination: A case report 1.229
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 1.219
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination 1.170
Urticaria and angioedema as possible misleading skin symptoms in families with hereditary angioedema 1.157
An uncommon association of antiphospholipid syndrome, selective IgA deficiency and resistant-to-treatment relapsing polychondritis: efficacy of Infliximab 1.157
Melkersson-Rosenthal Syndrome: A case report 1.150
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor 1.140
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination 1.136
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 1.091
COVID-19 Case Fatality Ratio of Latino America Countries with Temperate Climate Partially Follows European and Oceania Trends According to Seasonal Change 1.091
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma 1.088
Idiopathic pyoderma gangrenosum: Successful resolution with Infliximab therapy and proinflammatory cytokines assessment 1.077
Metabolomics, microbiota, and in vivo and in vitro biomarkers in type 2 severe asthma: A perspective review 1.071
Olfactory Function Is Impaired in Patients with Mastocytosis 1.068
Angioedema without wheals: a retrospective analysis of a single center cohort 1.065
Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination 1.061
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor 1.059
Raynaud's phenomenon and scleroderma associated with silicone gel breast implants: An example of Asia syndrome 1.046
Systemic reactive (AA) amyloidosis in the course of common variable immunodeficiency 1.010
Oxidative stress in hereditary angioedema caused by C1 inhibitor deficiency: An interesting finding that deserves further studies 1.001
Adult antibody deficiency syndrome and Henoch-Schoenlein Purpura: a report of two cases 969
A promising new treatment for SAPHO syndrome that deserves further studies 938
Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: A case report 926
Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab 898
Previous functional social and behavioral rhythms affect resilience to COVID-19-related stress among old adults 890
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 875
A Novel Mutation in the SERPING1 Gene in Patients with Hereditary Angioedema and a Coexistent Complement Deficiency 867
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 867
Salivary Cystatin D Interactome in Patients with Systemic Mastocytosis: An Exploratory Study 854
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G 852
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic. Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H 827
Cofactors, age at onset, allergic comorbidities and gender are different in patients sensitized to omega-5 gliadin and Pru p 3 770
Aspects of hereditary angioedema genotyping in the era of NGS: The case of F12 gene = Wybrane aspekty genotypowania wrodzonego obrzȩku naczynioruchowego w erze NGS: Gen F12 760
Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study 759
Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic 744
Totale 187.861
Categoria #
all - tutte 267.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 267.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022.402 0 0 0 0 9.052 6.511 3.543 787 490 573 501 945
2020/202144.906 1.061 1.527 1.511 11.946 8.988 5.090 3.203 3.109 1.519 2.594 2.618 1.740
2021/202212.565 1.277 721 586 986 922 896 795 607 1.311 1.144 1.659 1.661
2022/202317.536 1.347 2.302 2.432 1.366 1.532 1.814 944 1.546 1.052 991 1.336 874
2023/202420.785 1.275 781 979 1.614 1.945 3.424 3.046 1.666 992 1.354 1.797 1.912
2024/202564.654 15.887 35.053 7.619 4.366 1.729 0 0 0 0 0 0 0
Totale 216.953